Vice President, Marketing and Strategy, Mylan North America @ Mylan
Senior Associate (Private Equity) @ Friedman Fleischer & Lowe
President, Care Management Division @ Kindred Healthcare
Broad based leader as both President and Executive of medium-sized and large (multi-billion) business lines, divisions, and companies and private equity professional. Currently lead healthcare service delivery division, led healthcare services delivery division, led co-led branded and diversified pharma business unit, led global and regional marketing and commercial organizations in medical devices and pharma, led business development
Broad based leader as both President and Executive of medium-sized and large (multi-billion) business lines, divisions, and companies and private equity professional. Currently lead healthcare service delivery division, led healthcare services delivery division, led co-led branded and diversified pharma business unit, led global and regional marketing and commercial organizations in medical devices and pharma, led business development function in medical devices, and led major corporate strategy initiatives for multiple (three) industry leading Fortune 500 healthcare companies. Executed acquisitions and equity investments and managed portfolio companies in numerous industries for current and past companies and at leading private equity and investment banking firms.
MBA, Master's in Accounting and Financial Management, BA in Economics and Pre-Med, Lean Sigma Green Belt, QFD (Quality Function Deployment) Green Belt, and other sales and marketing and operational certifications. Small company investor and board member. YPO member. Regular conference / event speaker.
Executive Vice President, Kindred; President, Kindred Rehabilitation Services @ Lead the $2 billion Rehab Division at Kindred, consisting of 7 business segments, including freestanding IRFs (inpatient rehabilitation facilities ("rehab hospitals")) subsequent to the Centerre acquisition (January, 2015), acute rehab units in hospitals, outpatient rehab clinics, contract therapy in med/surg units of hospitals, long-term hospitals, skilled nursing facilities, and assisted / independent living facilities, 3rd party Part B therapy billing, and therapist staffing. The largest rehabilitation company in the United States, with over 25,000 employees / caregivers in over 2,300 locations. The second largest freestanding IRF company (with a unique joint venture model in partnerships with leading hospital systems) and largest IRF (including ARUs) company in the U.S. Driving leadership and growth through service, clinical, systems, sales, and people focused strategic initiatives, organic new facility developments, and differentiated business / corporate development partnerships. Executive Vice Presdient of Kindred Healthcare and Member of the Executive Committee of Kindred (NYSE: KND; over 100,000 employees operating in 46 states). From March 2015 to Present (10 months) Louisville, Kentucky AreaPresident, Care Management Division @ Led the Care Management division (including the Home Health & Hospice business, Home Based Primary Care, and integrated care management platforms and business models) with its 10,000 employees and healthcare professionals in 170 sites across the country. Completed and integrated numerous acquisitions, including Gentiva, and oversaw dramatic growth in the division. Reported to the President and COO and member of the Executive Committee of Kindred (NYSE: KND; 70,000 employees operating in 46 states). From July 2013 to April 2015 (1 year 10 months) Global Vice President, Marketing, Strategy and Commercial Development; Co-Lead Business Unit @ Led global marketing, strategy and commercial development for Mylan Specialty and co-led billion dollar division in the Office of the President. Business unit sold all of Mylan’s branded products across consumer, office based physician, hospital, pharmacy, and payor channels in the allergy, respiratory, anesthesia, pain, and CNS therapy areas today. Led function (managing five brands, including EpiPen) consisting of strategy, business development, product planning, brand management, DTC (direct-to-consumer), digital, market expansion, professional affairs, public relations, advocacy, market research, managed markets, marketing operations, and sales effectiveness activities. Co-led organization decision making. From September 2012 to June 2013 (10 months) Vice President, Marketing and Strategy, Mylan North America @ Led Marketing and Strategy (and various Sales initiatives) for Mylan’s North American platform ($3 billion business supplying 1 in 10 U.S. prescriptions) covering branded, branded generic, and generic products across four businesses, multiple channels (retail and specialty pharmacy, office based physicians, hospital, and payers), multiple technologies (oral solid, liquid capsule, transdermal, injectable, and inhalable), and 20 therapeutic categories. Ran strategy processes and ongoing strategic evaluations, including preparing for and defining biogeneric initiatives. Strategies and tactics included launching a new global master brand, launching numerous milestone products, and growing share of existing products. From May 2011 to September 2012 (1 year 5 months) Global Senior Director - Continuous Glucose Monitoring and Connectivity @ Led commercial activities for the Continuous Glucose Monitoring (“CGM”) and Connectivity business (six product lines) at the world’s leading medical device company (and at the $1.3 billion division). Managed both upstream Product Planning (new product definition and developments) and downstream Product Marketing (market research, brand management (STP, core message platform, creative execution), market development, direct-to-consumer, product/customer education, competition, pricing, forecasting, sales integration, training and support) teams to grow existing products and launch new products. CGM coordination over R&D, Manufacturing, Quality, Clinical, Regulatory, Customer Service, Education, and Sales. Lean Sigma and QFD (Quality Function Deployment) training and Green Belts. From 2008 to May 2011 (3 years) Business Development Lead @ Created, prioritized and executed on strategies and growth initiatives in driving business development activities for multiple divisions ($1.5 billion) of the company. Performed diligence on and executed supply, joint development, license, distribution, and commercialization agreements, equity investments, new company formations, acquisitions, and (EU) divestitures in both medical devices and drug/device combination therapies. Venture Manager for partnered projects encompassing novel therapies. Core Team for development of new drug/device therapy. Led portfolio prioritization process and Research, Engineering, Clinical, and Manufacturing teams in product, market and financial assessments to execute milestone based business plans. Co-led the overall Medtronic Strategic Plan. Patient Access Acceleration ("PAA") training and neuroscience courses. From 2006 to 2008 (2 years) Senior Associate (Private Equity) @ One of ten professionals investing an $800 million second private equity fund ($1.2 billion assets under management at the time) focused on leveraged acquisitions of growth companies and growth equity investments. Led cross-functional deal teams in executing transactions. Conducted business due diligence, structured investments and drafted proposals, developed detailed financial analyses and operating scenarios, negotiated deal documents, and coordinated debt financings and legal and accounting reviews. Evaluated markets and company strengths and weaknesses in due diligence, conducted detailed product, marketing, R&D, customer, supply chain, and facility reviews, assessed value propositions and management. Supported and developed portfolio company strategy and operations, regularly met with senior operating executives, developed financial reporting packages, drafted quarterly reports and annual reunderwriting reviews, wrote final investment memoranda and maintained intermediary relationships. Examined opportunities across a range of sectors including consumer products, business and financial services, IT, healthcare, industrial, and education. From 2002 to 2005 (3 years) Associate (Private Equity) @ Worked closely with firm’s four founding Partners (as first hire after formation) since inception of inaugural $350 million private equity fund. Involvement in all aspects of leveraged buyout and equity investment activities across a wide range of industries. Portfolio company interim CFO and Board Member. Led portfolio company budgets and strategies. From 1998 to 2000 (2 years) Analyst (Investment Banking) - M&A and Principal Real Estate @ Financial Analyst, Investment Banking Division, Mergers & Acquisitions: Financial Institutions Group.
Analyzed and executed mergers, acquisitions and divestitures for major financial institutions. Responsibilities included detailed valuation, analysis of financial impact and evaluation of strategic alternatives for financial institutions. Closed multiple sellside acquisitions that were the largest ever at the time. Provided M&A analysis for confidential Morgan Stanley strategic initiatives.
Financial Analyst, Investment Banking Division, Real Estate Group. Evaluated principal investments for $1.5 billion real estate merchant banking fund. Performed M&A advisory, refinancings and equity offerings for REITs. From 1996 to 1998 (2 years)
MBA, General Management @ Harvard Business School From 2001 to 2002 AB, Economics, Pre-Medical Curriculum @ Princeton University From 1992 to 1996 Master's of Accounting and Financial Management, Accounting and Finance, 4.0 GPA. @ Keller Graduate School of Management From 2010 to 2012 St. Louis Country Day High School From 1992 to 1996 Jon Rousseau is skilled in: Mergers, Business Development, Cross-functional Team Leadership, Business Strategy, Private Equity, Venture Capital, Accounting, Financial Analysis, Corporate Finance, Medical Devices, Biotechnology, Pharma, CNS, Diabetes, Allergy, Respiratory, Anesthesia, Pain, MS, Oncology, RA, Education, Business Services, Financial Services, Consumer Products Industries, Portfolio Management
Looking for a different
Get an email address for anyone on LinkedIn with the ContactOut Chrome extension